1. |
Thornley B, Adams C. Content and quality of 2000 controlled trials in schizophrenia over 50 years. BMJ, 1998, 317(7167): 1181-1184.
|
2. |
Adams CE, Awad G, Rathbone J, et al. Chlorpromazine versus placebo for schizophrenia. Cochrane Database Syst Rev, 2007, 18(2): CD000284.
|
3. |
Kirkham JJ, Gorst S, Altman DG, et al. COS-STAR: a reporting guideline for studies developing core outcome sets (protocol). Trials, 2015, 16: 373.
|
4. |
Williamson PR, Altman DG, Blazeby JM, et al. Driving up the quality and relevance of research through the use of agreed core outcomes. J Health Serv Res Policy, 2012, 17(1): 1-2.
|
5. |
Gargon E, Gurung B, Medley N, et al. Choosing important health outcomes for comparative effectiveness research: a systematic review. PLoS One, 2014, 9(6): e99111.
|
6. |
Gorst SL, Gargon E, Clarke M, et al. Choosing important health outcomes for comparative effectiveness research: an updated review and user survey. PLoS One, 2016, 11(1): e0146444.
|
7. |
Williamson PR, Altman DG, Blazeby JM, et al. Developing core outcome sets for clinical trials: issues to consider. Trials, 2012, 13: 132.
|
8. |
Chalmers I, Glasziou P. Avoidable waste in the production and reporting of research evidence. Lancet, 2009, 374(9683): 86-89.
|
9. |
Kirkham JJ, Gorst S, Altman DG, et al. Core Outcome Set-STAndards for reporting: the COS-STAR statement. PLoS Med, 2016, 13(10): e1002148.
|
10. |
Moher D, Schulz KF, Simera I, et al. Guidance for developers of health research reporting guidelines. PloS Med, 2010, 7(2): e1000217.
|
11. |
Schulz KF, Altman DG, Moher D, et al. CONSORT 2010 statement: updated guidelines for reporting parallel group randomised trials. PLoS Med, 2010, 7(3): e1000251.
|